Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense and Assets by Segment (Detail)

v3.22.0.1
Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense and Assets by Segment (Detail) - USD ($)
 12 Months Ended
Nov. 30, 2021
Nov. 30, 2020
Segment Reporting Information [Line Items]    
Total net revenue $ 28,884,902 $ 31,147,593
Total cost of sales 8,989,736 9,657,442
Total operating profit 4,003,122 7,661,597
Total depreciation and amortization 834,845 166,437
Total interest expense 1,378,926 1,544,017
Total assets 60,662,076 46,200,094
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 834,845 166,437
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 28,397,401 30,176,852
Total cost of sales 7,351,410 7,689,608
Total operating profit 6,347,061 9,928,886
Total assets 50,170,887 34,215,780
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 806,230 138,859
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 111,400 244,187
Total cost of sales 154,140 156,111
Total operating profit (70,335) 60,499
Total assets 250,591 302,683
PrepaCyte CB [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 27,595 27,578
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 376,101 726,554
Total cost of sales 1,484,186 1,811,723
Total operating profit (2,273,604) (2,327,788)
Total assets 10,240,598 $ 11,681,631
Public Cord Blood Banking [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization $ 1,020